News & Media

Latest News

Filter Your Search

Pilot Study Shows Even Short-Term 'Vaping' Causes Inflammation in Non-Smokers

E-cigarette use is rising at concerning levels among both smokers and non-smokers, and new research data suggests that even short-term e-cig use can cause cellular inflammation in never-smoker adults. OSUCCC – James researchers report the first evidence of biological changes correlated with e-cig use in never-smokers in the journal Cancer Prevention Research. Read More

E-cigarette use is rising at concerning levels among both smokers and non-smokers, and new research data suggests that even short-term e-cig use can cause cellular inflammation in never-smoker adults. OSUCCC – James researchers report the first evidence of biological changes correlated with e-cig use in never-smokers in the journal Cancer Prevention Research. Read More

Ohio State Research Discovery Enters Phase I Clinical Testing

A new targeted oral therapy – developed through research discoveries at the OSUCCC – James – is being offered as an experimental treatment option for patients with certain advanced cancers, including lymphoma. Known only as PRT543 while in testing, this targeted treatment molecule is among the first in an emerging class of drugs called PRMT5 inhibitors. Read More

A new targeted oral therapy – developed through research discoveries at the OSUCCC – James – is being offered as an experimental treatment option for patients with certain advanced cancers, including lymphoma. Known only as PRT543 while in testing, this targeted treatment molecule is among the first in an emerging class of drugs called PRMT5 inhibitors. Read More

Ohio State College of Pharmacy and OSUCCC – James Collaborate to Support Cancer Drug Discovery

The Ohio State University College of Pharmacy and OSUCCC – James have initiated a 10-year partnership to expand drug discovery and development in cancer and cancer-related diseases. Read More

The Ohio State University College of Pharmacy and OSUCCC – James have initiated a 10-year partnership to expand drug discovery and development in cancer and cancer-related diseases. Read More

Find an Expert

See All Experts

Search Our Media Library

See All Images

Contact Media Staff

Amanda Harper

Director of Media Relations


614-685-5420 (direct)


614-293-3737 (main)


Amanda.Harper2@osumc.edu


Media staff are available by calling 614-293-3737 Monday through Friday between 8 a.m. and 5 p.m.

 

If after hours, please call 614-293-8000 (ask the operator to page the hospital administrative manager).